Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4

Conditions

Melanoma 4Skin Neoplasms 3Neoplasms 3Neoplasm Metastasis 2

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 136Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 68fludarabine phosphate 62Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Cisplatin 36CTLA-4 Antigen 36Specimen Handling 35Magnetic Resonance Spectroscopy 35Carboplatin 35cobimetinib 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Melanoma × Allovectin-7 × Dermatologic × Clear all
NCT00395070 2013-09-13

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Vical

Phase 3 Completed
390 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

NCT00003646 2011-07-07

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Vical

Phase 2 Completed
78 enrolled
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

NCT00044356 2011-07-07

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Vical

Phase 2 Completed
133 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Neoplasms

NCT00003647 2008-07-25

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Vical

Phase 3 Completed
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡